Aytu BioPharma, Inc.

No trades
See on Supercharts

AYTU fundamentals

Aytu BioPharma, Inc. earnings and revenue

AYTU earnings for the last quarter are -1.93 USD whereas the estimation was -0.63 USD which accounts for -206.35% surprise. Company revenue for the same period amounts to 22.70M USD despite the estimated figure of 28.00M USD. Estimated earnings for the next quarter are -0.95 USD, and revenue is expected to reach 27.69M USD. Also watch annual changes over time to get a bigger picture of AYTU earnings and revenue dynamics.

EPS
‪0‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0‬
Reported
Estimate
Reported
Estimate
Surprise